Xtalks Webinars

March is Colorectal Cancer Awareness Month. While colorectal cancer rates are declining in adults 65+, they’re rising in younger adults, and the disease is now the leading cause of cancer death under 50. While the treatment landscape is evolving, screening needs to improve. Read more at buff.ly/GHdvsTd. #ColorectalCancer #EnoughCRC #CancerResearch #Pharma #Oncology

Workforce size shapes how healthcare organizations deliver care. See how the top 30 publicly traded healthcare companies compare by employee count, with recent updates at buff.ly/oWjn13B by @soumya2390. #HealthcareIndustry #HealthSystems #HealthcareWorkforce #CareDelivery #HealthServices

Several clinical-stage companies are entering public markets in 2026. Follow our pharma and biotech IPOs of 2026 blog featuring companies from oncology and immunology to AI-driven drug discovery at buff.ly/7B47lF8 by @soumya2390. #BiotechIPO #PharmaIPO #PharmaFunding #BiotechFunding #DrugDevelopment

From immune signaling to DNA repair targets, Eikon Therapeutics is building an oncology pipeline backed by a $381M Nasdaq IPO. Read about its immune-stimulating therapies now in clinical development at buff.ly/aI3j5on by @soumya2390. #EikonTherapeutics #BiotechIPO #CancerResearch #OncologyPipeline

DiaMedica Therapeutics’ CEO Rick Pauls discusses how placental ischemia drives preeclampsia, what it means for maternal and fetal outcomes and how ischemic blood flow biology is being studied across pregnancy and stroke in our latest Xtalks Clinical Edge interview at buff.ly/5RVxhSU by @soumya2390. #DiaMedica #IschemicDisease #StrokeResearch #Preeclampsia #KallikreinKininPathway #XtalksClinicalEdge

Move beyond "check-the-box" compliance and build a risk-based environmental monitoring (EM) program with Praveena Dhulipala, Bryant Goulet, and Kathleen Brennan in this webinar hosted by BA Sciences. They will explore how to align EM with modern regulatory expectations, including EU GMP Annex 1 and FDA guidance, to create a robust Contamination Control Strategy (CCS). Register to learn how to transform raw monitoring data into actionable quality intelligence that ensures inspection readiness and a demonstrable state of control for both sterile and non-sterile operations: buff.ly/9dgVR8N #BASciences #EnvironmentalMonitoring #PharmaManufacturing #Annex1 #GMP #ContaminationControl #QualityAssurance #SterileProcessing #Microbiology #FDACompliance #Cleanroom #DataTrending #CAPA #CompressedGas

Bridge the gap between pharmacogenomic (PGx) guidelines and clinical "go-live" with Emily Morris and Dr. Vicky Pratt in this webinar hosted by Agena Bioscience and GenXys. They will address the clinical necessity of DPYD testing to prevent severe toxicity from fluoropyrimidine therapy and provide a roadmap for scaling pre-treatment testing within health systems. Register now to discover how to overcome operational barriers through tailored PGx reporting, EHR integration, and workflow-aligned data that empowers providers to make safer, more consistent prescribing decisions: buff.ly/LDOVRnM #AgenaBioscience #GenXys #Pharmacogenomics #PGx #DPYD #PrecisionMedicine #ClinicalLab #EHR #HealthTech #Fluoropyrimidine #DrugSafety #Diagnostics #LabMedicine #Genomics

We’re proud to feature Xtalks Featured Community Member Lavanya Ramnath, Senior Regulatory Affairs Specialist at Insulet. Her work leading 510(k)s, IDEs and global submissions is helping bring next-gen medtech systems to patients worldwide. Read more at buff.ly/mII49H6. #LifeSciences #RegulatoryAffairs #Medtech #SaMD #DigitalHealth #FDA #GlobalRegulation #XtalksCommunity

Join us to streamline your endpoint adjudication workflows and keep critical trial decisions on track with Kristin Prusmack, Emily Trymbiski, and Catherine Tyner in this webinar hosted by AG Mednet. They will explore how adjudicated outcomes impact the critical path for interim analyses, DSMB safety assessments, and database lock. Register now to identify common operational failure points and learn field-tested practices that reduce cycle times while maintaining rigorous quality standards: buff.ly/P632RjC #AGMednet #ICON #EndpointAdjudication #ClinicalTrials #DMC #DSMB #ClinicalOperations #DrugDevelopment #TrialEfficiency #DataSafety #ClinicalData #Biotech #LifeSciences

Massive DEL libraries are common, but improved outcomes are not scalable. In this Xtalks Spotlight, Dr. Ying Zhang, Vice President of Discovery at X-Chem, shares what teams should look for beyond DEL library size when evaluating drug discovery partners. Read more at buff.ly/qWalsVo by @soumya2390. #DrugDiscovery #DEL #MedicinalChemistry #DNAEncodedLibrary

Medtech companies, including Medtronic and Endologix, have announced workforce reductions in 2026 as restructuring, facility closures and spinouts reshape the medical device sector. Get more details about the job cuts at buff.ly/uZVpyoE by @soumya2390. #MedtechLayoffs #MedicalDevices #MedtechIndustry

Looking for your next career move in pharma? Check out the top 15 best pharmaceutical companies to work for in 2026, as ranked by Forbes. Learn more about the companies and the big moves they’ve been making in the industry. Read more at buff.ly/QNl6WpO. #PharmaJobs #BestWorkplaces #LifeSciences

Join us to navigate the challenges of tumor heterogeneity and treatment resistance in oncology with Julian Goggi, PhD, in this webinar hosted by Perceptive Discovery. He will explore how combining radioligand therapy (RLT) with complementary modalities, such as DNA damage repair inhibitors, immunotherapy, and targeted therapies, can amplify DNA damage and sensitize tumors for better clinical outcomes. Register now to gain practical insights into the scientific rationale, imaging biomarkers, and dosimetry needed to design synergistic regimens and accelerate your RLT program from discovery to the clinic: buff.ly/8YTGWoW #PerceptiveDiscovery #RadioligandTherapy #Oncology #DrugDiscovery #NuclearMedicine #CancerResearch #Theranostics #CombinationTherapy #Biotech #TranslationalMedicine #PrecisionMedicine #TargetedAlphaTherapy

Dr. Steven Quay of @atossainc shares insights on drug development in ER+ breast cancer, including quality of life with endocrine therapy and how AI is reshaping drug development in this Xtalks Clinical Edge interview at buff.ly/RdYZ5VM by @soumya2390. #AtossaTherapeutics #ERPositiveBreastCancer #EndocrineTherapy #AdaptiveClinicalTrials #AIinDrugDevelopment #XtalksClinicalEdge

More healthcare layoffs are emerging in 2026. Hospitals and insurers, including Baystate Health, Point32Health and Hennepin Healthcare, have announced workforce reductions. Read more at buff.ly/k8or21I by @soumya2390. #HealthcareLayoffs #HealthcareWorkforce #HospitalLeadership #HealthInsurance #HealthcareIndustry

Our latest Xtalks Clinical Edge interview explores how the klotho gene is shaping next-gen ALS research. From delivery challenges to scalable manufacturing, Dr. Joseph Sinkule, CEO of @KlothoNeuroSci, breaks down the science at buff.ly/nPx2fld by @soumya2390. #ALSResearch #GeneTherapy #NeurodegenerativeDiseases #Biomarkers #KlothoGene #XtalksClinicalEdge

The FDA is launching a new integrated adverse event monitoring platform to “modernize” how adverse event reports are collected and analyzed across drugs, vaccines, medical devices and more. The agency says the system aims to streamline safety monitoring, improve transparency and lead to big cost savings. Read more at buff.ly/EGCZy00. #FDA #FDAAdverseEventMonitoring #FDARegulations

How are changes in MASH patient care reshaping clinical trial design and execution? In this Xtalks Spotlight, Dr. Naim Alkhouri, Chief Medical Officer at Summit Clinical Research, discusses patient selection, trial feasibility and the growing role of experience and infrastructure in MASH clinical trials. Read the interview at buff.ly/5VrbD6W by @soumya2390. #MASH #MASLD #LiverDisease #MASHTrials #ClinicalResearch

Join us to redefine endpoint strategies in multiple sclerosis (MS) drug development with Todd Rudo, MD, Laura Khurana, MPH, Douglas Arnold, MD, and Vrutangkumar V. Shah, PhD, in this webinar hosted by Clario. They will explore how traditional MS endpoints often miss subtle disease progression and how a new generation of digital tools, including AI-enabled quantitative imaging, optimized eCOA, and precision motion analysis, can provide the objective data needed to measure neurological change. Register now to learn how to improve endpoint sensitivity and data quality to drive more confident decision-making in your MS clinical programs: buff.ly/cJLrvjR #Clario #MultipleSclerosis #ClinicalTrials #DigitalEndpoints #MedicalImaging #eCOA #Neurology #DrugDevelopment #AIinHealthcare #MotionAnalysis #Biotech #MSResearch #ClinicalData

From diagnostics acquisitions to manufacturing expansions and digital health investments, see the latest new transactions in our medtech and medical device M&As 2026 blog at buff.ly/yokI6mO buff.ly/yokI6mO by @soumya2390. #Medtech #MedicalDevices #Diagnostics #HealthcareMergers #MedtechMA